Sartorius Aktiengesellschaft (SRT3.DE) Stock
Healthcare · Medical Instruments & Supplies · Member of MDAX, TecDAX
Sartorius Aktiengesellschaft (SRT3.DE) closed at EUR 258.00 on 2026-10-14, a change of +9.6 % over the past year, with a market capitalization of EUR 18.08B.
Sartorius Aktiengesellschaft recent closing prices
| Date | Close (EUR) |
|---|---|
| 2026-10-14 | 258.00 |
| 2026-10-13 | 251.30 |
| 2026-10-12 | 253.00 |
| 2026-10-09 | 253.00 |
| 2026-10-08 | 246.90 |
| 2026-10-07 | 260.00 |
| 2026-10-06 | 259.70 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Sartorius Aktiengesellschaft key figures
- Previous close
- EUR 258.00 (2026-10-14)
- 1-year change
- +9.6 %
- Market cap
- EUR 18.08B
- Enterprise value
- EUR 23.01B
- P/E ratio (trailing)
- 92.51
- P/E ratio (forward)
- 41.35
- EPS (trailing)
- 2.83
- EPS (forward)
- 6.33
- PEG ratio
- 0.94
- Price to book
- 6.68
- Revenue growth
- 3.1 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.74
- Short ratio
- n/a
- Employees
- 14,279
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Sartorius Aktiengesellschaft and compare it with other stocks.
Analyze SRT3.DEAll MDAX stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Sartorius Aktiengesellschaft shares.